Neuro-Oncology News

In a cohort of post-9/11 United States military veterans, moderate, severe and penetrating traumatic brain injuries were associated with the subsequent development of brain cancer, according to research from JAMA Network Open.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

The proportion of individuals with newly diagnosed cancer who lacked insurance in the U.S. declined significantly from 2010 to 2019, according to data published in Health Affairs Scholar.

Researchers at Sylvester Comprehensive Cancer Center at University of Miami devised an MRI-guided radiation therapy technique using machine learning that may allow for real-time monitoring of glioblastoma treatment response.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

Daphne Haas-Kogan, MD, MBA, has been appointed chair of the department of radiation oncology at Massachusetts General Hospital and chief of enterprise radiation oncology for Mass General Brigham.

An international team of investigators has identified a drug candidate that nearly doubles survival rates for patients with diffuse midline glioma, an aggressive type of childhood brain tumor.

The FDA announced several regulatory actions.

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.